Compare · NIVF vs SHC
NIVF vs SHC
Side-by-side comparison of NewGenIvf Group Limited (NIVF) and Sotera Health Company (SHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NIVF and SHC operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- SHC is the larger of the two at $5.06B, about 1121.3x NIVF ($4.5M).
- Over the past year, NIVF is down 99.7% and SHC is up 60.3% - SHC leads by 160.0 points.
- NIVF has hit the wire 7 times in the past 4 weeks while SHC has been quiet.
- SHC has more recent analyst coverage (25 ratings vs 0 for NIVF).
- Company
- NewGenIvf Group Limited
- Sotera Health Company
- Price
- $1.34-2.55%
- $17.75-2.93%
- Market cap
- $4.5M
- $5.06B
- 1M return
- -36.25%
- +10.63%
- 1Y return
- -99.74%
- +60.30%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 7
- 0
- Recent ratings
- 0
- 25
Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Latest NIVF
- SEC Form 4 filed by Director Siu Wing Fung Alfred
- SEC Form 4 filed by Director Fong Hei Yue Tina
- SEC Form 6-K filed by NewGenIvf Group Limited
- NewGen’s Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million
- SEC Form 6-K filed by NewGenIvf Group Limited
- SEC Form 6-K filed by NewGenIvf Group Limited
- NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization
- SEC Form 6-K filed by NewGenIvf Group Limited
- NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
- SEC Form 6-K filed by NewGenIvf Group Limited
Latest SHC
- Goldman initiated coverage on Sotera Health with a new price target
- SEC Form SD filed by Sotera Health Company
- Director Klee Ann R. was granted 14,970 shares, increasing direct ownership by 12% to 140,926 units (SEC Form 4)
- Chief Executive Officer Shader Alton was granted 579,573 shares (SEC Form 4)
- SEC Form 3 filed by new insider Shader Alton
- Director Kyle Richard G was granted 14,970 shares (SEC Form 4)
- Director Krause Kenneth D. was granted 14,970 shares (SEC Form 4)
- Director Cunningham Sean Laurence was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)
- Director Flynn Karen was granted 14,970 shares, increasing direct ownership by 38% to 54,191 units (SEC Form 4)
- Director Neary James was granted 14,970 shares, increasing direct ownership by 19% to 95,751 units (SEC Form 4)